Agenda and papers for DTn Strategy Meeting on 10th December 2021 

We are contacting you on behalf of the Joint British Diabetes Societies (JBDS) for inpatient care group. We are currently undertaking a review of our guideline "Glycaemic management during enteral feeding in stroke" and as part of this are reaching out to secondary care providers for help. While there is some evidence available, we would like to scope what current national practice is when providing glycaemic support for patient with diabetes or hyperglycaemia, regardless of reason for admission, during enteral feeding. 

ABCD is keen to ensure that all our members are aware of the withdrawing of the licence for the use of dapagloflozin in Type 1 diabetes .
Apologies if you've had this update from multiple sources.
We are currently collating feedback on this decision from experts in this area, to share with ABCD members to ensure that people with Type 1 diabetes get the best care and can make informed decisions. 
 

JBDS is updating the ‘Variable rate intravenous insulin infusion (VRIII) for medical inpatients with diabetes’ guideline and we need your help.

We need to collect evidence and are asking UK diabetes teams to let us know what they are currently doing by completing online forms.  This can be done either by downloading the form from https://forms.office.com/r/BTM64H2qMj or by scanning the attached QR code.

We are looking to get information on 5 people on a VRIII from each hospital

Webinar Programme

9.30 Overview of each system & the settings that are adjustable, Helen Brown

10.00 Expectations, Goals & a structured approach to Data Review, Dr Charlotte Boughton

10.30 Getting the basics right, Emma Musgrave

10.50 Break